Idexx Laboratories Inc /De
IDXX
Revenue
975.54M
▼-28.04M▼-2.79%
3 Months ChangeAssets
3.35B
▼-64.10M▼-1.88%
3 Months ChangeLiabilities
1.73B
▼-101.90M▼-5.55%
3 Months ChangeFree Cash Flow
168.31M
▲23.91M▲16.56%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-31
Form 10-Q
ID: 0000874716-24-000139
2024-10-31
Form 8-K
ID: 0001104659-24-112826
2024-08-06
Form 10-Q
ID: 0000874716-24-000121
2024-08-06
Form 8-K
ID: 0001104659-24-086074
2024-05-10
Form 8-K
ID: 0000874716-24-000107
2024-05-01
Form 10-Q
ID: 0000874716-24-000083
2024-05-01
Form 8-K
ID: 0001104659-24-055201
2024-02-05
Form 8-K
ID: 0001157523-24-000165
2023-12-07
Form 8-K
ID: 0000874716-23-000143
2023-11-01
Form 10-Q
ID: 0000874716-23-000128